Americas Tops the Postpartum Hemorrhage Devices Market

[junkie-button url=”” style=”grey” size=”medium” type=”round” target=”_blank”] HOME [/junkie-button]

The report segments the global postpartum hemorrhage devices market by product (uterine balloon tamponade, uniject prefilled injection system, and NASG) and by geography (the Americas, EMEA, and APAC). It provides a detailed illustration of the major factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Here are some key findings of the global postpartum hemorrhage devices market according to Technavio healthcare and life sciences researchers:

  • Increasing complications and risk factors for PPH: a major market driver
  • Increasing focus on development of low-cost PPH treatment devices: a key market trend
  • The Americas dominated the global postpartum hemorrhage devices market with around 40% share in 2017
  • BD, Cook Medical, C. R. Bard, Teleflex, Utah Medical Products, and ZOEX are some of the players in the market

Save more with Technavio. Buy 2 reports and get the third for free: View Technavio’s latest discounts and promotions

Increasing complications and risk factors for PPH: a major market driver

Increasing complications and risk factors for PPH is one of the major factors driving the global postpartum hemorrhage devices market. In 2015, more than 250,000 women across the globe died due to complications associated with pregnancy and childbirth. Approximately, one maternal death occurs in every 25 women suffering from complications that cause long-lasting sequelae. Pregnancy-related complications such as multiple births, preterm births, and macrosomia increase the incidence of PPH. Risk factors such as uterine atony, trauma, retained placenta, obesity, and bleeding disorders also increase the chances of PPH.

According to a senior analyst at Technavio for research on orthopedics and medical devices, “Uterine atony is the most common cause of severe PPH in the first 24 hours after childbirth. Trauma is the major non-obstetric cause of death among pregnant women. Approximately 90% of the traumatic injuries during pregnancy are classified as minor, yet nearly six or seven out of ten fetal losses after trauma is a result of minor injuries. It is estimated that the incidence rate of retained placenta is approximately one in 1,000 delivers. However, the case fatality rate can be as high as 100 in 1,000 deliveries.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Americas: largest postpartum hemorrhage devices market

The global PPH devices market was dominated by the Americas, accounting for a share of around 40%. The market dominance by the Americas is because of the high incidence of PPH, high hospital delivery rate, increase in medical complications related to pregnancy, high awareness among end-users about advanced PPH treatments, advanced healthcare infrastructure, and the increased healthcare expenditure. But compared to the Americas, APAC is estimated to have a faster growth rate during the forecast period due to the high patient base, huge untapped market potential, growing economy, increasing healthcare spending, and rapidly improving healthcare infrastructure.

Increasing focus on development of low-cost PPH treatment devices: a key market trend

Uterine balloon tamponade is the standard of care in several hospitals around the world. However, most of the hospitals are deterring from its adoption, as many of the manufactured medical balloons can only be used once and can cost over USD 200 per piece. Therefore, some players are increasingly concentrating on developing low-cost alternative PPH treatment devices. For instance, Massachusetts General Hospital’s Division of Global Health and Human Rights has developed an ultra-low-cost Postpartum Hemorrhage Package with Uterine Balloon Tamponade (ESM-UBT) that consists of a condom tied to a Foley catheter, for less than USD 5. Hence, the increasing focus on the development of low-cost PPH treatment devices is expected to drive the global PPH devices market.


For additional information, visit here.